147 related articles for article (PubMed ID: 38644103)
1. Precise timing of audiovisual stimulation conquers chemobrain.
Mehl LC; Gibson EM
Trends Cancer; 2024 May; 10(5):386-388. PubMed ID: 38644103
[TBL] [Abstract][Full Text] [Related]
2. Gamma entrainment using audiovisual stimuli alleviates chemobrain pathology and cognitive impairment induced by chemotherapy in mice.
Kim T; James BT; Kahn MC; Blanco-Duque C; Abdurrob F; Islam MR; Lavoie NS; Kellis M; Tsai LH
Sci Transl Med; 2024 Mar; 16(737):eadf4601. PubMed ID: 38446899
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment.
Gibson EM; Nagaraja S; Ocampo A; Tam LT; Wood LS; Pallegar PN; Greene JJ; Geraghty AC; Goldstein AK; Ni L; Woo PJ; Barres BA; Liddelow S; Vogel H; Monje M
Cell; 2019 Jan; 176(1-2):43-55.e13. PubMed ID: 30528430
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg1 Prevents Chemotherapy-Induced Cognitive Impairment: Associations with Microglia-Mediated Cytokines, Neuroinflammation, and Neuroplasticity.
Shi DD; Huang YH; Lai CSW; Dong CM; Ho LC; Li XY; Wu EX; Li Q; Wang XM; Chen YJ; Chung SK; Zhang ZJ
Mol Neurobiol; 2019 Aug; 56(8):5626-5642. PubMed ID: 30659419
[TBL] [Abstract][Full Text] [Related]
6. Exploring Novel Therapeutic Avenues for Chemotherapy Related Cognitive Impairment.
Dietrich J; Parsons MW; Santarnecchi E
Cancer Res; 2024 Apr; ():. PubMed ID: 38657103
[TBL] [Abstract][Full Text] [Related]
7. A Review on the Neuroprotective Effect of Berberine against Chemotherapy- induced Cognitive Impairment.
Sahu K; Singh S; Devi B; Singh C; Singh A
Curr Drug Targets; 2022; 23(9):913-923. PubMed ID: 35240956
[TBL] [Abstract][Full Text] [Related]
8. An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.
Das A; Ranadive N; Kinra M; Nampoothiri M; Arora D; Mudgal J
Curr Neuropharmacol; 2020; 18(9):838-851. PubMed ID: 32091339
[TBL] [Abstract][Full Text] [Related]
9. Methodological shortcomings of preclinical research on chemotherapy-induced cognitive impairment.
Ossorio-Salazar VA; D'Hooge R
Neurosci Biobehav Rev; 2023 Jul; 150():105198. PubMed ID: 37105339
[No Abstract] [Full Text] [Related]
10. Chemotherapy and cognitive impairment: An animal model approach.
Winocur G
Can J Exp Psychol; 2017 Dec; 71(4):265-273. PubMed ID: 29215907
[TBL] [Abstract][Full Text] [Related]
11. [An overview of the research of cancer-related cognitive impairment].
Ferencz V; S Nagy Z; Tóth M
Orv Hetil; 2019 Sep; 160(38):1495-1502. PubMed ID: 31537098
[TBL] [Abstract][Full Text] [Related]
12. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
Dias-Carvalho A; Ferreira M; Ferreira R; Bastos ML; Sá SI; Capela JP; Carvalho F; Costa VM
Arch Toxicol; 2022 Jan; 96(1):11-78. PubMed ID: 34725718
[TBL] [Abstract][Full Text] [Related]
13. Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice.
Liu Y; Reiken S; Dridi H; Yuan Q; Mohammad KS; Trivedi T; Miotto MC; Wedderburn-Pugh K; Sittenfeld L; Kerley Y; Meyer JA; Peters JS; Persohn SC; Bedwell AA; Figueiredo LL; Suresh S; She Y; Soni RK; Territo PR; Marks AR; Guise TA
Sci Transl Med; 2023 Sep; 15(715):eadf8977. PubMed ID: 37756377
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinically relevant rodent model of methotrexate-induced cognitive impairment.
Berlin C; Lange K; Lekaye HC; Hopland K; Phillips S; Piao J; Tabar V
Neuro Oncol; 2020 Aug; 22(8):1126-1137. PubMed ID: 32242229
[TBL] [Abstract][Full Text] [Related]
15. CMF and MET treatment induce cognitive impairment through upregulation of IL-1α in rat brain.
Alhowail AH; Almogbel YS; Abdellatif AAH; Alsalehi NF; Alghenaim FA; Aldubayan MA; Felemban SG
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4385-4393. PubMed ID: 34227073
[TBL] [Abstract][Full Text] [Related]
16. Similar neurocognitive patterns in patients treated with lenalidomide: chemobrain effect?
Calvi E; Marchetti M; Santagata F; Luppi C; Coppo E; Massaia M; Isaia GC
Neurocase; 2019 Dec; 25(6):259-262. PubMed ID: 31522586
[No Abstract] [Full Text] [Related]
17. Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats.
Lomeli N; Di K; Czerniawski J; Guzowski JF; Bota DA
Free Radic Biol Med; 2017 Jan; 102():274-286. PubMed ID: 27908784
[TBL] [Abstract][Full Text] [Related]
18. Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology.
Allegra A; Innao V; Basile G; Pugliese M; Allegra AG; Pulvirenti N; Musolino C
Expert Rev Hematol; 2020 Apr; 13(4):393-404. PubMed ID: 32129131
[No Abstract] [Full Text] [Related]
19. Neuroprotective effect of Mulmina Mango against chemotherapy-induced cognitive decline in mouse model of mammary carcinoma.
John J; Kinra M; Ranadive N; Keni R; Nayak PG; Jagdale RN; Ahmed SM; Raghavendra KV; Mudgal J; Nandakumar K
Sci Rep; 2022 Feb; 12(1):3072. PubMed ID: 35197512
[TBL] [Abstract][Full Text] [Related]
20. Gamma oscillations and application of 40-Hz audiovisual stimulation to improve brain function.
Chen X; Shi X; Wu Y; Zhou Z; Chen S; Han Y; Shan C
Brain Behav; 2022 Dec; 12(12):e2811. PubMed ID: 36374520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
